1 PROCUREMENT AND CONSTRUCTION OF PREMIUM NEW DISTRIBUTION CENTER (EOI ANNOUNCEMENT) WWW.MONTSAME.MN PUBLISHED:2025/10/10      2 SIGNING OF GRANT AGREEMENT WITH MONGOLIA:CONTRIBUTING TO STRENGTHENING THE FOUNDATION FOR DEVELOPING ENGINEERS THROUGH A JAPANESE-STYLE PRACTICAL TRAINING FACILITY AND EQUIPMENT WWW.JICA.GO.JP PUBLISHED:2025/10/10      3 PETRO MATAD SHARES SURGE AFTER MONGOLIA TESTS ‘EXCEEDED EXPECTATIONS’ WWW.UKINVESTORMAGAZINE.CO.UK PUBLISHED:2025/10/09      4 ULAANBAATAR TO SUPPLY 170,000 HOUSEHOLDS WITH SEMI-COKE BRIQUETTES WWW.MONTSAME.MN PUBLISHED:2025/10/09      5 100.9 KILOMETERS OF ROADS UPGRADED IN ULAANBAATAR THIS YEAR WWW.MONTSAME.MN PUBLISHED:2025/10/09      6 ADVISED TO MANAGE STRATEGIC MINERAL RESOURCES PRUDENTLY WWW.MONTSAME.MN PUBLISHED:2025/10/09      7 30 KILOMETERS OF RAINWATER DRAINAGE PIPELINES TO BE INSTALLED IN 2026 WWW.MONTSAME.MN PUBLISHED:2025/10/09      8 ARCHAEOLOGISTS USE INNOVATIVE TECHNOLOGIES IN SEARCH FOR GENGHIS KHAN'S TOMB WWW.BGNES.COM PUBLISHED:2025/10/09      9 MONGOLIA BUILDS AWARENESS OF UN WATER CONVENTION WITH A VIEW TO STRENGTHENING TRANSBOUNDARY WATER COOPERATION WWW.UNECE.ORG PUBLISHED:2025/10/09      10 CHINA-EUROPE FREIGHT TRAINS PASSING THROUGH CENTRAL CORRIDOR TOP 3,000, 39 DAYS AHEAD OF 2024 WWW.GLOBALTIMES.CN PUBLISHED:2025/10/09      ЕВРОПЫН ХОЛБОО БОЛОН МОНГОЛ УЛСЫН БИЗНЕС, ХӨРӨНГӨ ОРУУЛАЛТЫН ФОРУМ БОЛНО WWW.NEWS.MN НИЙТЭЛСЭН:2025/10/10     ДҮҮЖИН ЗАМЫН ТЭЭВЭР ТӨСӨЛ 38 ХУВИЙН ГҮЙЦЭТГЭЛТЭЙ ҮРГЭЛЖИЛЖ БАЙНА WWW.EAGLE.MN НИЙТЭЛСЭН:2025/10/10     МОНГОЛООС 20 САЯАР АВДАГ ШОНХОР ШУВУУ САУДЫН АРАБД 622 САЯ ТӨГРӨГӨӨР ЗАРАГДЛАА WWW.EGUUR.MN НИЙТЭЛСЭН:2025/10/09     АЗИЙН ХӨГЖЛИЙН БАНКНААС ЗЭЭЛ АВЧ 31 СУРГУУЛЬ, 9 ЦЭЦЭРЛЭГ БАРИНА WWW.ITOIM.MN НИЙТЭЛСЭН:2025/10/09     Д.ЦОЛМОНГ ОЮУ ТОЛГОЙ ХХК-ИЙН ТУЗ-ИЙН ГИШҮҮНЭЭР ТОМИЛЖЭЭ WWW.ITOIM.MN НИЙТЭЛСЭН:2025/10/09     Б.ЭНХБАЯРЫГ ХЗДХ-ИЙН САЙДААР ТОМИЛОХ ТАНИЛЦУУЛГЫГ ХОЙШЛУУЛЖЭЭ WWW.NEWS.MN НИЙТЭЛСЭН:2025/10/09     ХАГАС КОКСОН ШАХМАЛ ТҮЛШИЙГ ӨНӨӨДРӨӨС БОРЛУУЛЖ ЭХЭЛЛЭЭ WWW.ITOIM.MN НИЙТЭЛСЭН:2025/10/09     МОНГОЛЫН ЭДИЙН ЗАСАГТ ТУЛГАРЧ БУЙ ЭРСДЭЛИЙГ ОЛОН УЛСЫН БАЙГУУЛЛАГУУД ИНГЭЖ ТОДОРХОЙЛОВ WWW.ITOIM.MN НИЙТЭЛСЭН:2025/10/08     ЕРӨНХИЙЛӨГЧ У.ХҮРЭЛСҮХИЙН ЭНЭТХЭГТ ХИЙХ АЙЛЧЛАЛ НЬ СТРАТЕГИЙН ТҮНШЛЭЛИЙГ ДАХИН ТОДОРХОЙЛНО WWW.ITOIM.MN НИЙТЭЛСЭН:2025/10/08     "ОЮУ ТОЛГОЙ" ХХК-ИЙН ТУЗ-ИЙН ГИШҮҮНЭЭС Э.БАЯСГАЛАНГ ЧӨЛӨӨЛЖЭЭ WWW.EGUUR.MN НИЙТЭЛСЭН:2025/10/08    

Pfizer to invest $350 million in China biotech hub, first in Asia www.reuters.com

Pfizer Inc (PFE.N) will invest $350 million to build a biotech center in China, the latest in a series of moves by pharma industry giants to set up shop in the world's no. 2 drugs market with the aim of securing faster approvals for their products.
 
The facility in eastern Hangzhou region - Pfizer's first biotech center in Asia - is expected to be completed by 2018, the firm said in a statement on Tuesday.
 
Global "Big Pharma" is increasingly looking for smart ways to tap China's healthcare market, estimated by consultancy IMS Health to be worth around $185 billion by 2018. From investing in China facilities to acquisitions, licensing deals and joint ventures, the aim is to seek an edge in dealings with domestic regulators and government.
 
John Young, group president for Pfizer's essential health division, said in the statement that the Hangzhou facility should "help support China's aim to increase the complexity and value of its manufacturing sector by 2025".
 
Pfizer said it would "work closely" with local regulators to bring the drugs "to market as soon as possible". The center will mostly on biologic drugs - made from living micro-organisms rather than chemically synthesized - and lower-cost 'biosimilars', of generic versions of biologics.
 
Pharmaceutical executives have long complained about the slow process of getting drugs to market in China, while others have run up against regulatory roadblocks. Pfizer had to close its vaccine business in the country last year after a license for its top-selling vaccine Prevenar was not renewed.
 
China's overall healthcare spending is set to hit $1.3 trillion by 2020, but drug market growth has slowed to a low single-digit percentage pace from over 20 percent just four years ago as branded generics have lost their shine and Beijing has looked to drive down prices to keep a lid on costs.


Published Date:2016-06-28